Svrcek M, Jourdan F, Sebbagh N, Couvelard A, Chatelain D, Mourra N, Olschwang S, Wendum D, Fléjou J-F
Department of Pathology, Saint-Antoine Hospital, AP-HP, F75571 Paris cedex 12, France.
J Clin Pathol. 2003 Dec;56(12):898-903. doi: 10.1136/jcp.56.12.898.
Primary adenocarcinomas of the small intestine are rare, and the genetic mechanisms involved in their carcinogenesis remain unclear.
To examine the expression of candidate proteins in small intestinal adenocarcinomas by immunohistochemistry performed on tissue microarrays (TMAs).
Twenty seven primary sporadic small intestinal adenocarcinomas were analysed. The TMA technique was validated by comparing immunohistochemical labelling of hMLH1 and hMSH2 on TMAs and the tissue sections they derived from. The expression of Smad4, hMSH6, beta catenin, and p53 was investigated and results compared with those obtained in 14 malignant ampullary tumours.
TMA technology with threefold redundancy adequately represented the immunohistochemical pattern of small intestinal adenocarcinomas. Loss of hMLH1 expression, but not hMSH2 or hMSH6, was seen in two of 27 small intestinal adenocarcinomas. All ampullary tumours showed nuclear staining for hMSH2 and hMSH6. One case showed lack of immunostaining for hMLH1. Smad4 expression was absent in five small intestinal adenocarcinomas and two ampullary tumours. Overexpression of p53 was detected in the nuclei of 14 of the 27 small intestinal adenocarcinomas, and five of the 14 ampullary tumours. Nuclear or cytoplasmic expression of beta catenin was present in all specimens.
Inactivation of the SMAD4/DPC4 gene seems to be involved in small intestinal adenocarcinoma tumorigenesis. Overexpression of p53 and abnormal expression of beta catenin are two common events, unlike the loss of expression of the DNA mismatch repair proteins (hMLH1, hMSH2, and hMSH6). The carcinogenetic process appears to be similar in small intestinal adenocarcinomas and malignant ampullary tumours.
小肠原发性腺癌较为罕见,其致癌的遗传机制尚不清楚。
通过组织芯片(TMA)上的免疫组织化学检测小肠腺癌中候选蛋白的表达。
分析27例原发性散发性小肠腺癌。通过比较TMA及其来源的组织切片上hMLH1和hMSH2的免疫组织化学标记来验证TMA技术。研究Smad4、hMSH6、β-连环蛋白和p53的表达,并将结果与14例壶腹恶性肿瘤的结果进行比较。
具有三倍冗余的TMA技术充分代表了小肠腺癌的免疫组织化学模式。在27例小肠腺癌中有2例出现hMLH1表达缺失,但hMSH2或hMSH6未缺失。所有壶腹肿瘤hMSH2和hMSH6均呈核染色。1例hMLH1免疫染色缺失。5例小肠腺癌和2例壶腹肿瘤中未检测到Smad4表达。27例小肠腺癌中有14例、14例壶腹肿瘤中有5例在细胞核中检测到p53过表达。所有标本中均存在β-连环蛋白的核或细胞质表达。
SMAD4/DPC4基因的失活似乎参与小肠腺癌的肿瘤发生。p53过表达和β-连环蛋白异常表达是两个常见事件,与DNA错配修复蛋白(hMLH1、hMSH2和hMSH6)表达缺失不同。小肠腺癌和壶腹恶性肿瘤的致癌过程似乎相似。